Union Health Care Plans File Antitrust Action Against Takeda
A group of union health care plans have accused Takeda Pharmaceuticals and other drugmakers of engaging in a price-fixing scheme that reduced competition for a gout drug after entering into deals...To view the full article, register now.
Already a subscriber? Click here to view full article